Aurion Biotech is a clinical-stage biotechnology company dedicated to restoring vision through innovative regenerative therapies. With offices in Seattle, Boston, and Tokyo, the company focuses on developing treatments for corneal conditions, including its first candidate for corneal edema, which has received regulatory approval in Japan. Recognized with the Prix Galien award for best start-up in biotech, Aurion Biotech is rapidly expanding and seeks motivated individuals from diverse backgrounds to join its mission. The company values stewardship, transformation, and grit, and offers a supportive work environment with robust benefits, competitive compensation, and a culture that promotes collaboration and innovation.